Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hereditary Sensory and Autonomic Neuropathies | 3 | 2015 | 40 | 0.740 |
Why?
|
| Superoxide Dismutase | 7 | 2014 | 596 | 0.630 |
Why?
|
| Serine C-Palmitoyltransferase | 2 | 2009 | 39 | 0.630 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2014 | 77 | 0.510 |
Why?
|
| Bronchial Provocation Tests | 1 | 2014 | 227 | 0.490 |
Why?
|
| Methacholine Chloride | 1 | 2014 | 233 | 0.490 |
Why?
|
| Inhalation | 1 | 2014 | 143 | 0.480 |
Why?
|
| Bronchoconstriction | 1 | 2014 | 141 | 0.480 |
Why?
|
| Spinal Cord Injuries | 4 | 2006 | 930 | 0.460 |
Why?
|
| Airway Resistance | 1 | 2014 | 404 | 0.460 |
Why?
|
| Capnography | 1 | 2013 | 89 | 0.430 |
Why?
|
| Amyotrophic Lateral Sclerosis | 8 | 2016 | 1421 | 0.420 |
Why?
|
| Forced Expiratory Volume | 2 | 2013 | 1741 | 0.380 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 933 | 0.370 |
Why?
|
| Evans Blue | 1 | 2008 | 45 | 0.330 |
Why?
|
| Tetanus Toxin | 1 | 2008 | 49 | 0.330 |
Why?
|
| Sphingolipids | 1 | 2009 | 159 | 0.320 |
Why?
|
| Motor Neuron Disease | 2 | 2004 | 106 | 0.290 |
Why?
|
| Spirometry | 3 | 2013 | 862 | 0.290 |
Why?
|
| Protein Subunits | 1 | 2009 | 960 | 0.270 |
Why?
|
| Lung Diseases | 1 | 2016 | 1884 | 0.270 |
Why?
|
| Coloring Agents | 1 | 2008 | 565 | 0.270 |
Why?
|
| Hypertension, Pulmonary | 1 | 2016 | 1527 | 0.260 |
Why?
|
| Horner Syndrome | 1 | 2005 | 37 | 0.250 |
Why?
|
| Anterior Horn Cells | 1 | 2004 | 19 | 0.250 |
Why?
|
| Adenoviridae | 1 | 2008 | 1096 | 0.240 |
Why?
|
| Speech Intelligibility | 1 | 2003 | 81 | 0.230 |
Why?
|
| Respiration Disorders | 1 | 2006 | 370 | 0.220 |
Why?
|
| Genes, Dominant | 1 | 2005 | 880 | 0.220 |
Why?
|
| Blood-Brain Barrier | 1 | 2008 | 1015 | 0.210 |
Why?
|
| Motor Neurons | 3 | 2014 | 851 | 0.210 |
Why?
|
| Ventilators, Mechanical | 1 | 2003 | 292 | 0.200 |
Why?
|
| Cyclosporine | 1 | 2004 | 784 | 0.190 |
Why?
|
| Aquaporins | 1 | 2002 | 174 | 0.190 |
Why?
|
| Melatonin | 1 | 2005 | 720 | 0.170 |
Why?
|
| Pulmonary Circulation | 1 | 2002 | 739 | 0.170 |
Why?
|
| Cell Death | 1 | 2004 | 1695 | 0.160 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 3038 | 0.160 |
Why?
|
| Capillary Permeability | 1 | 2002 | 798 | 0.160 |
Why?
|
| Gene Silencing | 1 | 2004 | 1538 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 1434 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 3502 | 0.150 |
Why?
|
| Gene Expression | 1 | 2009 | 7790 | 0.140 |
Why?
|
| Mexiletine | 1 | 2016 | 31 | 0.140 |
Why?
|
| Neuroblastoma | 1 | 2004 | 1225 | 0.140 |
Why?
|
| Peptide Fragments | 1 | 2008 | 5095 | 0.130 |
Why?
|
| RNA, Small Interfering | 1 | 2004 | 3504 | 0.120 |
Why?
|
| Cricetinae | 2 | 2009 | 2471 | 0.120 |
Why?
|
| Neural Conduction | 1 | 2015 | 468 | 0.110 |
Why?
|
| Phenotype | 2 | 2014 | 16331 | 0.110 |
Why?
|
| Mutation | 5 | 2014 | 29717 | 0.110 |
Why?
|
| Exhalation | 1 | 2013 | 166 | 0.100 |
Why?
|
| Mitochondria | 2 | 2004 | 3520 | 0.100 |
Why?
|
| Bronchial Spasm | 1 | 2011 | 73 | 0.100 |
Why?
|
| Vital Capacity | 1 | 2013 | 922 | 0.090 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2010 | 193 | 0.080 |
Why?
|
| Mice, Transgenic | 4 | 2011 | 9735 | 0.080 |
Why?
|
| Pulmonary Edema | 1 | 2011 | 415 | 0.080 |
Why?
|
| Carbon Dioxide | 1 | 2013 | 1141 | 0.080 |
Why?
|
| alpha-Galactosidase | 1 | 2008 | 57 | 0.080 |
Why?
|
| Lac Operon | 1 | 2008 | 238 | 0.080 |
Why?
|
| Mice, Inbred C3H | 1 | 2009 | 964 | 0.080 |
Why?
|
| Benzodiazepinones | 1 | 2008 | 51 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2016 | 20086 | 0.080 |
Why?
|
| Convulsants | 1 | 2008 | 70 | 0.080 |
Why?
|
| Spinal Cord | 2 | 2008 | 1807 | 0.080 |
Why?
|
| Speech, Alaryngeal | 1 | 2006 | 32 | 0.070 |
Why?
|
| Xenon | 1 | 2007 | 110 | 0.070 |
Why?
|
| Aging | 1 | 2005 | 8626 | 0.070 |
Why?
|
| Transfection | 2 | 2005 | 5892 | 0.070 |
Why?
|
| Nerve Degeneration | 1 | 2011 | 748 | 0.070 |
Why?
|
| Breathing Exercises | 1 | 2006 | 53 | 0.070 |
Why?
|
| Receptors, GABA | 1 | 2008 | 288 | 0.070 |
Why?
|
| Pancreas, Exocrine | 1 | 2005 | 45 | 0.070 |
Why?
|
| Lung | 3 | 2013 | 9826 | 0.060 |
Why?
|
| Respiratory Paralysis | 1 | 2005 | 31 | 0.060 |
Why?
|
| Positive-Pressure Respiration | 2 | 2011 | 632 | 0.060 |
Why?
|
| Pupil | 1 | 2005 | 149 | 0.060 |
Why?
|
| Cell Aggregation | 1 | 2004 | 244 | 0.060 |
Why?
|
| Cricetulus | 1 | 2005 | 817 | 0.060 |
Why?
|
| Male | 14 | 2016 | 349538 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2011 | 1357 | 0.060 |
Why?
|
| Cough | 1 | 2006 | 555 | 0.050 |
Why?
|
| CHO Cells | 1 | 2005 | 1407 | 0.050 |
Why?
|
| Mice | 7 | 2011 | 81045 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2006 | 547 | 0.050 |
Why?
|
| Aquaporin 1 | 1 | 2002 | 58 | 0.050 |
Why?
|
| Creatine | 1 | 2004 | 421 | 0.050 |
Why?
|
| Disulfides | 1 | 2004 | 457 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2008 | 791 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2004 | 2255 | 0.050 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2002 | 319 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 1456 | 0.050 |
Why?
|
| Lung Transplantation | 1 | 2010 | 1155 | 0.050 |
Why?
|
| Cervical Vertebrae | 2 | 2005 | 973 | 0.050 |
Why?
|
| Skin | 1 | 2015 | 4353 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3862 | 0.050 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2004 | 475 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 2699 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2008 | 1354 | 0.050 |
Why?
|
| Humans | 21 | 2016 | 742088 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2013 | 21719 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 1723 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 2049 | 0.050 |
Why?
|
| Blood Group Antigens | 1 | 2002 | 179 | 0.050 |
Why?
|
| Thoracic Vertebrae | 1 | 2005 | 604 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1727 | 0.040 |
Why?
|
| DNA Primers | 1 | 2004 | 2892 | 0.040 |
Why?
|
| Reference Standards | 1 | 2003 | 1020 | 0.040 |
Why?
|
| Adult | 10 | 2015 | 213712 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 6608 | 0.040 |
Why?
|
| Dyspnea | 1 | 2006 | 1298 | 0.040 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2005 | 685 | 0.040 |
Why?
|
| Animals | 8 | 2011 | 168561 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2714 | 0.040 |
Why?
|
| Female | 14 | 2016 | 379592 | 0.040 |
Why?
|
| Cell Survival | 2 | 2008 | 5872 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2004 | 3127 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2004 | 941 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2005 | 1882 | 0.040 |
Why?
|
| Axons | 1 | 2005 | 1681 | 0.040 |
Why?
|
| Middle Aged | 9 | 2016 | 213127 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2010 | 4393 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 3847 | 0.040 |
Why?
|
| Muscle Cramp | 1 | 2016 | 35 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2006 | 2924 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2004 | 6313 | 0.030 |
Why?
|
| Binding Sites | 1 | 2004 | 6115 | 0.030 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2005 | 1181 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2006 | 2566 | 0.030 |
Why?
|
| Equipment Design | 1 | 2003 | 3582 | 0.030 |
Why?
|
| Apoptosis | 3 | 2011 | 9715 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 15530 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2009 | 14554 | 0.030 |
Why?
|
| Aged | 6 | 2015 | 162944 | 0.030 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2015 | 98 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2005 | 2623 | 0.030 |
Why?
|
| Stents | 1 | 2005 | 3276 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2008 | 13029 | 0.030 |
Why?
|
| Base Sequence | 1 | 2004 | 12797 | 0.030 |
Why?
|
| Protein Binding | 1 | 2004 | 9387 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 963 | 0.020 |
Why?
|
| Postural Balance | 1 | 2016 | 620 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2004 | 3957 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2004 | 3258 | 0.020 |
Why?
|
| Liver | 1 | 2004 | 7470 | 0.020 |
Why?
|
| Axotomy | 1 | 2008 | 74 | 0.020 |
Why?
|
| Logistic Models | 1 | 2003 | 13403 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 16665 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2011 | 1613 | 0.020 |
Why?
|
| Vibrissae | 1 | 2008 | 125 | 0.020 |
Why?
|
| Disease Progression | 2 | 2016 | 13256 | 0.020 |
Why?
|
| Fructose | 1 | 2008 | 288 | 0.020 |
Why?
|
| Action Potentials | 1 | 2014 | 1814 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2008 | 368 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2008 | 1581 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 11363 | 0.020 |
Why?
|
| Facial Nerve | 1 | 2008 | 271 | 0.020 |
Why?
|
| Data Collection | 1 | 2015 | 3339 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 2008 | 517 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 2008 | 508 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2014 | 19223 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2010 | 1839 | 0.020 |
Why?
|
| Survival Rate | 2 | 2010 | 12773 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 19862 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2008 | 609 | 0.020 |
Why?
|
| Electron Transport Complex IV | 1 | 2004 | 189 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 2004 | 210 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 2004 | 235 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2008 | 1661 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2004 | 668 | 0.010 |
Why?
|
| Premedication | 1 | 2004 | 257 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 10943 | 0.010 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2008 | 740 | 0.010 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 1728 | 0.010 |
Why?
|
| Dimerization | 1 | 2004 | 893 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2008 | 2723 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 24913 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 759 | 0.010 |
Why?
|
| Dogs | 1 | 2007 | 3910 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 39004 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 40054 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 563 | 0.010 |
Why?
|
| Caspases | 1 | 2004 | 928 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 686 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 2004 | 647 | 0.010 |
Why?
|
| Echocardiography | 1 | 2011 | 5097 | 0.010 |
Why?
|
| Prognosis | 2 | 2010 | 29010 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2004 | 1372 | 0.010 |
Why?
|
| Point Mutation | 1 | 2004 | 1624 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2004 | 1167 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2008 | 21821 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2011 | 6440 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 3701 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 57683 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 2024 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2004 | 1333 | 0.010 |
Why?
|
| Aspirin | 1 | 2008 | 3278 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2014 | 11470 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2004 | 3913 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 12958 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 12071 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3920 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2015 | 77098 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2004 | 5454 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2004 | 2896 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2004 | 3081 | 0.010 |
Why?
|
| Adolescent | 2 | 2015 | 85649 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18006 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 9941 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 24265 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2004 | 9846 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 4465 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 7721 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 62966 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 56350 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 9410 | 0.000 |
Why?
|
| Incidence | 1 | 2004 | 20928 | 0.000 |
Why?
|
| Neurons | 1 | 2004 | 9325 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2008 | 53187 | 0.000 |
Why?
|
| Inflammation | 1 | 2004 | 10578 | 0.000 |
Why?
|
| United States | 1 | 2010 | 69693 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2004 | 40450 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2004 | 23387 | 0.000 |
Why?
|
| Risk Factors | 1 | 2004 | 72145 | 0.000 |
Why?
|
| Child | 1 | 2004 | 77478 | 0.000 |
Why?
|
Concepts
(226)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_